Gretchen Kimmick

8PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsInformation systems development methodologies and practicePredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 26, 2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

|Jan 28, 2026
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2.

Nadine M Tung, Mark E Robson, Tianyu Li

|Dec 15, 2022
Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials.

Gretchen Kimmick, Mina S Sedrak, Grant Williams

|Jan 07, 2021
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16.

Shlomit S Shachar, Allison M Deal, Katherine E Reeder-Hayes

|Apr 01, 2020
The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part II: Metastatic Disease.

Addie Hill, Eutiquio Gutierrez, Jennifer Liu

|Feb 27, 2020
The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.

Sarah Sammons, Mina S Sedrak, Gretchen G Kimmick

Pageof 2

Frequent Collaborators

3 joint publications

Mina S Sedrak

2 joint publications

Sarah Sammons

2 joint publications

Lisa A Carey

1 joint publications

Allison M Deal